NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

ETON | NASDAQ

$59.19 $0.01 | 0.02%

SIGNAL:

|2026-09-24 |F&G 64 |RSI 55.7

Add to favoritesFavorite

Company Overview:

Market Cap: $1.69B

Trailing PE: 153.9x

FWD PE *: 33x

Payout Ratio (TTM): —

52-Week Range: $14.27 - $66.37

* Forward PE is based on street estimates.

7.9 Year ETON Performance Metrics:

Total Return (with DRIP): 847% (32.92% CAGR)

Total Return (no DRIP): 847% (32.92% CAGR)

Share Price: 847% (32.92% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $94,704

Total Return $ (with DRIP): $84,704

ETON Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

ETON Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

ETON Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

ETON - Revenue

ETON Revenue CAGR:1Y: 98.59%2Y: 103.53%5Y: 65.07%10Y: 0.00%

ETON - Earnings Per Share (EPS)

ETON EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Net Income

🔓 See the full chart40% off right now · 7-day free trial

ETON Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

ETON EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

ETON Free Cash Flow CAGR:1Y: -8.78%2Y: 140.52%5Y: 0.00%10Y: 0.00%

ETON - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

ETON Free Cash Flow / Share CAGR:1Y: -11.25%2Y: 132.27%5Y: 0.00%10Y: 0.00%

ETON - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

ETON Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

ETON Gross Profit CAGR:1Y: 113.12%2Y: 112.53%5Y: 54.03%10Y: 0.00%

ETON - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

ETON Shares Outstanding CAGR:1Y: 21.92%2Y: 12.78%5Y: 5.40%10Y: 0.00%

ETON - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

ETON Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

ETON Stock-Based Comp CAGR:1Y: -29.96%2Y: 32.20%5Y: 11.92%10Y: 0.00%

ETON - Expenses

🔓 See the full chart40% off right now · 7-day free trial

ETON Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 10.76%10Y: 0.00%

ETON - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

ETON - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

ETON - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

ETON - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

ETON - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

ETON - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

ETON - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

ETON Revenue CAGR:1Y: 98.59%2Y: 103.53%5Y: 65.07%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ETON - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ETON Actual Revenue CAGR:1Y: 98.59%2Y: 103.53%5Y: 65.07%10Y: 0.00%

ETON - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ETON Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ETON Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ETON Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ETON - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

ETON Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

ETON Gross Profit Margin CAGR:1Y: 7.32%2Y: 4.43%5Y: -6.69%10Y: 0.00%

ETON - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

ETON Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

ETON Price To Sales Ratio CAGR:1Y: 31.48%2Y: 66.01%5Y: -12.06%10Y: 0.00%

ETON - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

ETON Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ETON - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

ETON Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for ETON

Based on past 7.9-year performance, here are ETON growth metrics:

Share price CAGR of +32.92%
Dividend CAGR of +0%

Using ETON CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	ETON (DRIP)	ETON - No DRIP
Current Price	$59.19	$59.19
Start Shares	168.95	168.95
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	168.95	168.95
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$59.19	$59.19
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - ETON

NOTE: Above numbers are our estimate based on ETON's Dividend and Price CAGR over past 7.9 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

Company Info

Eton Pharmaceuticals, Inc. (ETON) had its IPO on 2018-11-14, and is traded on NASDAQ stock exchange.

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

ETON website: https://www.etonpharma.com

Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)

Pro

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Stock Fundamentals
DCF valuation modeling
Compare Stocks Side-by-Side
Revenue & EPS Estimates

Try it free for 7 days

You save $125.40 (55%)

DCF Model — ETON

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $59.19

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →